» Articles » PMID: 31236336

Heavy Metal Imaging in Fibrotic Human Kidney Tissue Using the Synchrotron X-ray Fluorescence Microprobe

Overview
Date 2019 Jun 26
PMID 31236336
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormally high exposure to heavy metals and their accumulation in some tissues are recognized as causes of many acute and chronic human diseases. Because of the roles many metals have in normal human physiology, proving cause and effect between exposure to heavy metals and pathogenesis of disease is problematic. Therefore, many illnesses that develop through occupational and environmental exposure are not considered directly related to heavy metal toxicity. The high sensitivity and spatial resolution of elements using the synchrotron X-ray fluorescence microprobe (XFM) may give a robust means to investigate spatial distribution of heavy metals in correlation with specific pathologies. For example, proven presence of different heavy metals may correlate spatially with kidney fibrosis, suggesting a mechanistic link between heavy metal-induced fibrosis and chronic kidney disease. One specific example that may benefit from such an analysis relates to a cluster of people with chronic kidney disease of unknown cause (CKDu), in a significant proportion of the population of the North Central Province of Sri Lanka. Here, it was postulated that heavy metal exposure, in particular of cadmium, in foods and agriculture may be one cause of end-stage kidney disease and premature death of patients with CKDu. Synchrotron methods had not been applied previously to this particular problem. This manuscript provides a brief review of the literature and reports some pilot data from an investigation of localization of kidney fibrosis in CKDu with selected heavy metals including cadmium.

Citing Articles

Mercuric Chloride Induced Nephrotoxicity: Ameliorative Effect of Leaves Confirmed by Histopathology, Immunohistochemistry, and Gene Expression Studies.

Maria Francis Y, Karunakaran B, Ashfaq F, Qattan M, Ahmad I, Alkhathami A ACS Omega. 2023; 8(24):21696-21708.

PMID: 37360438 PMC: 10286259. DOI: 10.1021/acsomega.3c01045.


Cadmium-Induced Proteinuria: Mechanistic Insights from Dose-Effect Analyses.

Satarug S, Vesey D, Gobe G Int J Mol Sci. 2023; 24(3).

PMID: 36768208 PMC: 9915107. DOI: 10.3390/ijms24031893.


Kidney Cadmium Concentrations in an Urban Sri Lankan Population: an Autopsy Study.

Gunawardena S, Ranasinghe M, Ranchamali T, Dileka P, Gunawardana J Biol Trace Elem Res. 2021; 199(11):4045-4054.

PMID: 33409914 DOI: 10.1007/s12011-020-02541-w.

References
1.
Satarug S, Baker J, Urbenjapol S, Haswell-Elkins M, Reilly P, Williams D . A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol Lett. 2002; 137(1-2):65-83. DOI: 10.1016/s0378-4274(02)00381-8. View

2.
Hasnain S . Synchrotron techniques for metalloproteins and human disease in post genome era. J Synchrotron Radiat. 2003; 11(Pt 1):7-11. DOI: 10.1107/s0909049503024166. View

3.
Nishijo M, Satarug S, Honda R, Tsuritani I, Aoshima K . The gender differences in health effects of environmental cadmium exposure and potential mechanisms. Mol Cell Biochem. 2004; 255(1-2):87-92. DOI: 10.1023/b:mcbi.0000007264.37170.39. View

4.
Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Baker J, Moore M . Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects. Toxicol Lett. 2004; 148(3):187-97. DOI: 10.1016/j.toxlet.2003.10.028. View

5.
Satarug S, Moore M . Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect. 2004; 112(10):1099-103. PMC: 1247384. DOI: 10.1289/ehp.6751. View